The ability of mTOR to integrate nutrient supply, bioenergetics and T cell functions, makes it a promising target for therapeutic intervention to suppress abnormal T cell differentiation during the early stages of RA (Perl, 2016). Here, MTOR is linked to rheumatoid arthritis.